$ACHN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHILLION PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHILLION PHARMACEUTICALS INC. Get notifications about new insider transactions in ACHILLION PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
Jan 26 2016 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Option Exercise | A | 7.61 | 142,000 | 1,080,620 | 142,000 | |
Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Barrish Joel C | Chief Scientific Of ... | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Apelian David | Chief Medical Offic ... | Option Exercise | A | 7.61 | 118,000 | 897,980 | 118,000 | |
Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Option Exercise | A | 7.61 | 118,000 | 897,980 | 118,000 | |
Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 7.61 | 400,000 | 3,044,000 | 400,000 | |
Jan 05 2016 | ACHN | ACHILLION PHARMACE ... | Barrish Joel C | Chief Scientific Of ... | Option Exercise | A | 10.35 | 250,000 | 2,587,500 | 250,000 | |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Apelian David | Chief Medical Offic ... | Option Exercise | M | 3.02 | 10,000 | 30,200 | 290,000 | |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Apelian David | Chief Medical Offic ... | Sell | S | 10.50 | 10,000 | 105,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Apelian David | Chief Medical Offic ... | Buy | M | 3.02 | 10,000 | 30,200 | 10,000 | 0 to 10 K |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Option Exercise | M | 1.05 | 43,500 | 45,675 | 0 | |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Sell | S | 10.08 | 43,500 | 438,480 | 0 | 43.5 K to 0 (-100.00 %) |
Dec 30 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Buy | M | 1.05 | 43,500 | 45,675 | 43,500 | 0 to 43.5 K |
Dec 16 2015 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Director | Option Exercise | A | 9.13 | 30,000 | 273,900 | 30,000 | |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.31 | 370 | 3,815 | 17,179 | 17.5 K to 17.2 K (-2.11 %) |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.31 | 49,630 | 511,685 | 2,317,797 | 2.4 M to 2.3 M (-2.10 %) |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.43 | 1,325 | 13,820 | 17,549 | 18.9 K to 17.5 K (-7.02 %) |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.43 | 177,749 | 1,853,922 | 2,367,427 | 2.5 M to 2.4 M (-6.98 %) |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.01 | 2,375 | 23,774 | 18,874 | 21.2 K to 18.9 K (-11.18 %) |
Nov 12 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 10.01 | 318,551 | 3,188,696 | 2,545,176 | 2.9 M to 2.5 M (-11.12 %) |
Sep 29 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 8.22 | 69 | 567 | 21,249 | 21.3 K to 21.2 K (-0.32 %) |
Sep 29 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 8.22 | 9,241 | 75,961 | 2,863,727 | 2.9 M to 2.9 M (-0.32 %) |
Aug 18 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 31,431 | 0 | 31,431 | 0 to 31.4 K |
Aug 18 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 483,521 | 0 | 0 | 483.5 K to 0 (-100.00 %) |
Aug 18 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | S | 7.51 | 37,843 | 284,201 | 21,318 | 59.2 K to 21.3 K (-63.97 %) |
May 22 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 222,630 | 0 | 483,521 | 260.9 K to 483.5 K (+85.33 %) |
May 22 2015 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 1,700,000 | 0 | 2,872,968 | 4.6 M to 2.9 M (-37.17 %) |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | EVP and CFO | Option Exercise | M | 4.00 | 13,125 | 52,500 | 0 | |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | EVP and CFO | Sell | S | 16.00 | 13,125 | 210,000 | 0 | 13.1 K to 0 (-100.00 %) |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | EVP and CFO | Buy | M | 4.00 | 13,125 | 52,500 | 13,125 | 0 to 13.1 K |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 3.02 | 100,000 | 302,000 | 300,000 | |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 15.00 | 100,000 | 1,500,000 | 0 | 100 K to 0 (-100.00 %) |
Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 3.02 | 100,000 | 302,000 | 100,000 | 0 to 100 K |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 3.50 | 1,552,000 | 5,432,000 | 4,816,562 | 3.3 M to 4.8 M (+47.54 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 4.00 | 400,000 | 1,600,000 | 5,216,562 | 4.8 M to 5.2 M (+8.30 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 4.00 | 200,000 | 800,000 | 5,416,562 | 5.2 M to 5.4 M (+3.83 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.26 | 135,800 | 985,908 | 5,280,762 | 5.4 M to 5.3 M (-2.51 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.38 | 50,051 | 369,376 | 5,230,711 | 5.3 M to 5.2 M (-0.95 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.35 | 49,354 | 362,505 | 5,181,357 | 5.2 M to 5.2 M (-0.94 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.33 | 4,424 | 32,428 | 5,176,933 | 5.2 M to 5.2 M (-0.09 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.30 | 77,600 | 566,480 | 5,099,333 | 5.2 M to 5.1 M (-1.50 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.42 | 27,783 | 206,128 | 5,071,550 | 5.1 M to 5.1 M (-0.54 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.42 | 5,665 | 42,006 | 5,065,885 | 5.1 M to 5.1 M (-0.11 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.40 | 26,539 | 196,481 | 5,039,346 | 5.1 M to 5 M (-0.52 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.48 | 2,328 | 17,413 | 5,037,018 | 5 M to 5 M (-0.05 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.42 | 77,600 | 575,994 | 4,959,418 | 5 M to 5 M (-1.54 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.53 | 91,801 | 690,913 | 4,867,617 | 5 M to 4.9 M (-1.85 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | S | 15.00 | 7,760 | 116,400 | 7,760 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | P | 7.50 | 7,760 | 58,200 | 7,760 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | S | 20.00 | 3,072 | 61,440 | 3,072 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | P | 7.50 | 3,072 | 23,040 | 3,072 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | S | 20.00 | 768 | 15,360 | 768 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | P | 7.50 | 768 | 5,760 | 768 | ||
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.27 | 18,857 | 136,996 | 4,848,760 | 4.9 M to 4.8 M (-0.39 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.21 | 7,761 | 55,918 | 4,856,521 | 4.8 M to 4.9 M (+0.16 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.21 | 4,190 | 30,189 | 4,860,711 | 4.9 M to 4.9 M (+0.09 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.20 | 6,906 | 49,689 | 4,867,617 | 4.9 M to 4.9 M (+0.14 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.30 | 38,800 | 283,240 | 4,828,817 | 4.9 M to 4.8 M (-0.80 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.21 | 19,400 | 139,777 | 4,848,217 | 4.8 M to 4.8 M (+0.40 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.18 | 19,400 | 139,292 | 4,867,617 | 4.8 M to 4.9 M (+0.40 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.39 | 38,500 | 245,823 | 4,906,117 | 4.9 M to 4.9 M (+0.79 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.49 | 77,000 | 499,345 | 4,983,117 | 4.9 M to 5 M (+1.57 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.58 | 38,500 | 253,330 | 5,021,617 | 5 M to 5 M (+0.77 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.58 | 115,500 | 759,413 | 5,137,117 | 5 M to 5.1 M (+2.30 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.76 | 52,652 | 356,164 | 5,189,769 | 5.1 M to 5.2 M (+1.02 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 6.87 | 4,312 | 29,641 | 5,185,457 | 5.2 M to 5.2 M (-0.08 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.69 | 23,100 | 154,590 | 5,208,557 | 5.2 M to 5.2 M (+0.45 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 6.86 | 9,951 | 68,307 | 5,198,606 | 5.2 M to 5.2 M (-0.19 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.75 | 38,500 | 259,844 | 5,237,106 | 5.2 M to 5.2 M (+0.74 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.30 | 77,000 | 485,100 | 5,314,106 | 5.2 M to 5.3 M (+1.47 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.11 | 23,100 | 164,336 | 5,291,006 | 5.3 M to 5.3 M (-0.43 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.98 | 23,100 | 161,319 | 5,314,106 | 5.3 M to 5.3 M (+0.44 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 6.95 | 3,377 | 23,479 | 5,310,729 | 5.3 M to 5.3 M (-0.06 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.91 | 6,453 | 44,558 | 5,317,182 | 5.3 M to 5.3 M (+0.12 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 6.90 | 11,441 | 78,943 | 5,328,623 | 5.3 M to 5.3 M (+0.22 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.19 | 40,829 | 293,756 | 5,287,794 | 5.3 M to 5.3 M (-0.77 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.15 | 14,592 | 104,333 | 5,273,202 | 5.3 M to 5.3 M (-0.28 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.19 | 37,250 | 268,003 | 5,310,452 | 5.3 M to 5.3 M (+0.71 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.26 | 7,862 | 57,040 | 5,302,590 | 5.3 M to 5.3 M (-0.15 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.23 | 38,400 | 277,674 | 5,340,990 | 5.3 M to 5.3 M (+0.72 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.16 | 24,883 | 178,162 | 5,365,873 | 5.3 M to 5.4 M (+0.47 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 7.21 | 38,400 | 276,960 | 5,327,473 | 5.4 M to 5.3 M (-0.72 %) | |
Jan 20 2015 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 7.09 | 38,400 | 272,387 | 5,365,873 | 5.3 M to 5.4 M (+0.72 %) | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Liotta Dennis | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | A | 13.24 | 110,000 | 1,456,400 | 110,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Shah Gautam | EVP and Chief Compl ... | Option Exercise | A | 13.24 | 95,000 | 1,257,800 | 95,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Apelian David | EVP and Chief Medic ... | Option Exercise | A | 13.24 | 175,000 | 2,317,000 | 175,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | EVP and CFO | Option Exercise | A | 13.24 | 110,000 | 1,456,400 | 110,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | A | 13.24 | 345,000 | 4,567,800 | 345,000 | |
Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | A | 13.24 | 25,000 | 331,000 | 25,000 | |
Oct 01 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.02 | 700,000 | 7,010,500 | 6,700,000 | 7.4 M to 6.7 M (-9.46 %) | |
Oct 01 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.11 | 411,000 | 4,153,319 | 7,400,000 | 7.8 M to 7.4 M (-5.26 %) | |
Oct 01 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.96 | 221,014 | 2,423,264 | 7,811,000 | 8 M to 7.8 M (-2.75 %) | |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.10 | 250,000 | 2,775,000 | 8,032,014 | 8.3 M to 8 M (-3.02 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 10.96 | 120,000 | 1,314,600 | 8,282,014 | 8.4 M to 8.3 M (-1.43 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.12 | 300,000 | 3,335,190 | 8,402,014 | 8.7 M to 8.4 M (-3.45 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.06 | 250,000 | 2,765,000 | 8,702,014 | 9 M to 8.7 M (-2.79 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.06 | 131,800 | 1,457,049 | 8,952,014 | 9.1 M to 9 M (-1.45 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.01 | 116,186 | 1,279,696 | 9,083,814 | 9.2 M to 9.1 M (-1.26 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.28 | 500,000 | 5,640,000 | 9,200,000 | 9.7 M to 9.2 M (-5.15 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.29 | 210,109 | 2,372,215 | 9,700,000 | 9.9 M to 9.7 M (-2.12 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.25 | 319,100 | 3,588,280 | 9,910,109 | 10.2 M to 9.9 M (-3.12 %) |
Sep 26 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.24 | 175,720 | 1,974,460 | 10,229,209 | 10.4 M to 10.2 M (-1.69 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.02 | 317,500 | 3,498,628 | 10,404,929 | 10.7 M to 10.4 M (-2.96 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.11 | 655,239 | 7,279,574 | 10,722,429 | 11.4 M to 10.7 M (-5.76 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.10 | 11,783 | 130,808 | 11,377,668 | 11.4 M to 11.4 M (-0.10 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.09 | 60,549 | 671,537 | 11,389,451 | 11.5 M to 11.4 M (-0.53 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.09 | 50,000 | 554,420 | 11,450,000 | 11.5 M to 11.5 M (-0.43 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.08 | 335,140 | 3,714,457 | 11,500,000 | 11.8 M to 11.5 M (-2.83 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.50 | 814,860 | 9,370,890 | 11,835,140 | 12.7 M to 11.8 M (-6.44 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.84 | 5,900 | 69,848 | 12,650,000 | 12.7 M to 12.7 M (-0.05 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.67 | 16,387 | 191,248 | 12,655,900 | 12.7 M to 12.7 M (-0.13 %) |
Sep 23 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.65 | 327,713 | 3,818,971 | 12,672,287 | 13 M to 12.7 M (-2.52 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.35 | 250,000 | 3,087,500 | 13,000,000 | 13.3 M to 13 M (-1.89 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.32 | 17,357 | 213,922 | 13,250,000 | 13.3 M to 13.3 M (-0.13 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.33 | 115,000 | 1,418,502 | 13,267,357 | 13.4 M to 13.3 M (-0.86 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.31 | 531,352 | 6,538,446 | 13,382,357 | 13.9 M to 13.4 M (-3.82 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.62 | 83,560 | 1,054,845 | 13,913,709 | 14 M to 13.9 M (-0.60 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.41 | 184,643 | 2,292,010 | 13,997,269 | 14.2 M to 14 M (-1.30 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.61 | 121,943 | 1,537,677 | 14,181,912 | 14.3 M to 14.2 M (-0.85 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.63 | 69,833 | 881,907 | 14,303,855 | 14.4 M to 14.3 M (-0.49 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 127,013.00 | 273,017 | 34,676,708,221 | 14,373,688 | 14.6 M to 14.4 M (-1.86 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.69 | 49,057 | 622,573 | 14,646,705 | 14.7 M to 14.6 M (-0.33 %) |
Sep 12 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.73 | 8,600 | 109,443 | 14,695,762 | 14.7 M to 14.7 M (-0.06 %) |
Sep 11 2014 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 100,995 | 0 | 260,891 | 159.9 K to 260.9 K (+63.16 %) |
Sep 11 2014 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 1,200,000 | 0 | 4,572,968 | 5.8 M to 4.6 M (-20.79 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.04 | 158,655 | 1,909,921 | 14,704,362 | 14.9 M to 14.7 M (-1.07 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 12.01 | 103,052 | 1,237,284 | 14,863,017 | 15 M to 14.9 M (-0.69 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.93 | 1,100 | 13,125 | 14,966,069 | 15 M to 15 M (-0.01 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.41 | 64,000 | 730,458 | 14,967,169 | 15 M to 15 M (-0.43 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.40 | 217,000 | 2,473,800 | 15,031,169 | 15.2 M to 15 M (-1.42 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.45 | 46,600 | 533,337 | 15,248,169 | 15.3 M to 15.2 M (-0.30 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.44 | 30,500 | 348,798 | 15,294,769 | 15.3 M to 15.3 M (-0.20 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.41 | 33,960 | 387,450 | 15,325,269 | 15.4 M to 15.3 M (-0.22 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.42 | 2,635 | 30,095 | 15,359,229 | 15.4 M to 15.4 M (-0.02 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.53 | 4,150 | 47,831 | 15,361,864 | 15.4 M to 15.4 M (-0.03 %) |
Sep 02 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.51 | 173,641 | 1,999,372 | 15,366,014 | 15.5 M to 15.4 M (-1.12 %) |
Aug 27 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.48 | 150,100 | 1,722,518 | 15,539,655 | 15.7 M to 15.5 M (-0.96 %) |
Aug 27 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.75 | 116,989 | 1,374,258 | 15,689,755 | 15.8 M to 15.7 M (-0.74 %) |
Aug 27 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 11.77 | 312,867 | 3,681,881 | 15,806,744 | 16.1 M to 15.8 M (-1.94 %) |